Sorrento’s and Yuhan’s Joint Venture, ImmuneOncia, receives Approval to begin clinical trial of Anti-PD-L1 Biotech Investing
NanoSphere Health Sciences Inc. Increases Capacity at Key Colorado Production Facility Biotech Investing
Isodiol International Inc. Receives Regulatory (ANVISA) Approval for Isodiolex for the Treatment of Epilepsy and Parkinson’s Biotech Investing
MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression Biotech Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness